HN2001000089A - Formulacion de tintes - Google Patents

Formulacion de tintes

Info

Publication number
HN2001000089A
HN2001000089A HN2001000089A HN2001000089A HN2001000089A HN 2001000089 A HN2001000089 A HN 2001000089A HN 2001000089 A HN2001000089 A HN 2001000089A HN 2001000089 A HN2001000089 A HN 2001000089A HN 2001000089 A HN2001000089 A HN 2001000089A
Authority
HN
Honduras
Prior art keywords
dyes
formulation
present
invention refers
refers
Prior art date
Application number
HN2001000089A
Other languages
English (en)
Original Assignee
J & P Coasts Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by J & P Coasts Ltd filed Critical J & P Coasts Ltd
Priority to HN2001000089A priority Critical patent/HN2001000089A/es
Publication of HN2001000089A publication Critical patent/HN2001000089A/es

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pens And Brushes (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A FORMULACION DE TINTES
HN2001000089A 2001-04-28 2001-04-28 Formulacion de tintes HN2001000089A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HN2001000089A HN2001000089A (es) 2001-04-28 2001-04-28 Formulacion de tintes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HN2001000089A HN2001000089A (es) 2001-04-28 2001-04-28 Formulacion de tintes

Publications (1)

Publication Number Publication Date
HN2001000089A true HN2001000089A (es) 2001-09-21

Family

ID=53190414

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2001000089A HN2001000089A (es) 2001-04-28 2001-04-28 Formulacion de tintes

Country Status (1)

Country Link
HN (1) HN2001000089A (es)

Similar Documents

Publication Publication Date Title
HN2001000139A (es) Interleuquina 2 estabilizada
HN1999000089A (es) Formulaciones de ziprasidona
HN1999000125A (es) Nuevos derivados sustituidos del pirazol
HN1998000159A (es) Derivados de 9- amino - 3 ceto eritromicina
DE60225040D1 (de) Montelukast-granulatformulierung
HN1998000030A (es) 2-amino-6-(4fenoxi-2-sustituido)-piridinas sustituidas
HN1998000106A (es) Composiciones parenterales de alatroflaxacino
DOP2002000371A (es) Fenil-heterociclil-eteres
HN1998000199A (es) Agentes terapeuticos
HN1998000102A (es) Composiciones solubilizadas de sertralina
HN2001000089A (es) Formulacion de tintes
CR8185A (es) Pirimidinas 2- sustituidas
HN2001000135A (es) Derivados de purina
HN1999000202A (es) Derivados de higromicina
HN2002000006A (es) Utilizacion de cromanos
HN2001200000A (es) Suspension de ziprasidona
HN2001200100A (es) Derivados de eteres de pirazol como agentes antinflamatorios analgesicos.
HN2000000242A (es) Derivados de higromicina
HN2001000102A (es) Derivados de tropano utiles en terapia
HN2000000188U (es) Arado combinado
HN1999000205A (es) Formulaciones antiparasitos
HN2001000126A (es) Derivados de 3-azabiciclo (3.1.0) hexano utiles en terapia
HN2002000368A (es) Composicion parental reconstituible
HN2000000083A (es) Complejo farmaceutico
HN2000000276A (es) Derivados de tiazolilamida